Authors:
Larsen, A
Kvien, TK
Schattenkirchner, M
Rau, R
Scott, DL
Smolen, JS
Rozman, B
Westhovens, R
Tikly, M
Oed, C
Rosenburg, R
Citation: A. Larsen et al., Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine, SC J RHEUM, 30(3), 2001, pp. 135-142
Authors:
Emery, P
Breedveld, FC
Lemmel, EM
Kaltwasser, JP
Dawes, PT
Gomor, B
Van den Bosch, F
Nordstrom, D
Bjorneboe, O
Dahl, R
Horslev-Petersen, K
de la Serna, AR
Molloy, M
Tikly, M
Oed, C
Rosenburg, R
Loew-Friedrich, I
Citation: P. Emery et al., A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis, RHEUMATOLOG, 39(6), 2000, pp. 655-665
Citation: M. Tikly et R. Tager, Re: Tager and Tikly. Clinical and laboratory manifestations of systemic sclerosis (scleroderma) in Black South Africans - Reply, RHEUMATOLOG, 39(2), 2000, pp. 222-222
Citation: M. Tikly et al., Rheumatology in Africa at the turn of the century - Report on the Third AFLAR Congress, Stellenbosch, South Africa, JCR-J CLIN, 6(2), 2000, pp. 103-106
Citation: Re. Tager et M. Tikly, Clinical and laboratory manifestations of systemic sclerosis (scleroderma)in Black South Africans, RHEUMATOLOG, 38(5), 1999, pp. 397-400
Authors:
Baerwald, CGO
Mok, CC
Fife, MS
Tikly, M
Lau, CS
Wordsworth, BP
Ollier, B
Panayi, GS
Lanchbury, JS
Citation: Cgo. Baerwald et al., Distribution of corticotropin-releasing hormone promoter polymorphism in different ethnic groups: evidence for natural selection in human populations, IMMUNOGENET, 49(10), 1999, pp. 894-899